Serious allergic reactions following tuberculin skin tests

CMAJ. Canadian Medical Association Journal

Volumn 173, Issue 1, 2005, Pages 34-

  Youssef, Elham ^a   Wooltorton, Eric ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; HIGH RISK POPULATION; HUMAN; HYPERSENSITIVITY; SHORT SURVEY; THROAT DISEASE; TUBERCULIN TEST; TUBERCULOSIS; URTICARIA;

EID: 22144496473     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050710     Document Type: Short Survey

References (3)

1. Sanofi Pasteur Limited, Health Canada's Health Products and Food Branch, Public Health Agency of Canada. Risk of serious allergic reactions following Tubersol [tuberculin purified protein derivative (Mantoux)] administration [Dear Health Care Professional letter]. Ottawa: Health Canada; 2005. Available: www.hc-sc.gc .ca/hpfb-dgpsa/tpd-dpt/tubersol_hpc_e .html (accessed 2005 Jun 8).
2. Menzies D, Nan Tannenbaum T, FitzGerald JM. Tuberculosis: 10. Prevention. CMAJ 1999;161(6):717-24.
3. National Advisory Committee on Immunization. Canadian immunization guide. 6th ed. Ottawa: Health Canada; 2002. p. 14.